Skip to content

SoftWave Provider? Click here to learn more about SoftWaveClinics.com

Sexual Health Research

Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy

Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy

A review of preclinical studies – Low-intensity extracorporeal shock wave therapy (LI-ESWT) is a novel treatment for erectile dysfunction (ED). Its ability to improve erectile function has been shown in patients with vasculogenic ED by many randomized-controlled trials againsts ham procedures....
Learn more about Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy
Low Intensity Extracorporeal Shock Wave Therapy Improves Erectile Function in a Model of Type II Diabetes Independently of NO/cGMP Pathway

Low Intensity Extracorporeal Shock Wave Therapy Improves Erectile Function in a Model of Type II Diabetes Independently of NO/cGMP Pathway

Erectile dysfunction is highly prevalent in type II diabetes mellitus.Low intensity extracorporeal shock wave therapy improves erectile function inpatients with erectile dysfunction of vasculogenic origin, including diabetes.However, its mode of action remains unknown. We investigated the effects of low intensity...
Learn more about Low Intensity Extracorporeal Shock Wave Therapy Improves Erectile Function in a Model of Type II Diabetes Independently of NO/cGMP Pathway
Extracorporeal Shock Wave Therapy for Treatment of Vulvodynia: A prospective, randomized, double-blind, placebo-controlled study

Extracorporeal Shock Wave Therapy for Treatment of Vulvodynia: A prospective, randomized, double-blind, placebo-controlled study

Currently, there are no effective therapy strategies for idiopathic, non-organic vulvodynia in women. ESWT (extracorporeal shock wave therapy) is a nonsurgical/noninvasive technique widely used to treat musculoskeletal diseases, muscle spasticity and hypertonia, renal and biliary calculi and urological disorders. Click...
Learn more about Extracorporeal Shock Wave Therapy for Treatment of Vulvodynia: A prospective, randomized, double-blind, placebo-controlled study
ISSWSH Abstract

ISSWSH Abstract

Click here to read more.
Learn more about ISSWSH Abstract
CM Shockwave Before And After Use

CM Shockwave Before And After Use

Click here to read more.
Learn more about CM Shockwave Before And After Use
Dr Irwin Goldstein Dinner Presentation – Nashville

Dr Irwin Goldstein Dinner Presentation – Nashville

Click here to read more.
Learn more about Dr Irwin Goldstein Dinner Presentation – Nashville
Shockwave Therapy Shows Promise in Treating Peyronie’s Disease

Shockwave Therapy Shows Promise in Treating Peyronie’s Disease

Title of study: A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease Authors: L Gao, S Qian, Z Tang, J Li, J Yuan Peyronie's disease (PD) is a condition that causes the penis to become curved and can lead...
Learn more about Shockwave Therapy Shows Promise in Treating Peyronie’s Disease
Extracorporeal shock wave therapy (ESWT) in urology:a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain

Extracorporeal shock wave therapy (ESWT) in urology:a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain

Grzegorz Lukasz Fojeck · Stefan Tiessen · Palle Jörn Sloth Osther 2017 – The objective was to evaluate high-level evidence studies of extracorporeal shock wave therapy (ESWT) for urological disorders. Click here to read more.
Learn more about Extracorporeal shock wave therapy (ESWT) in urology:a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain
Minimally invasive treatment of Peyronie’s disease: evidence-based progress

Minimally invasive treatment of Peyronie’s disease: evidence-based progress

Department of Urology, Eastern Virginia Medical School, Norfolk, VA, *Division of Urologic Surgery, University of North Carolina, Chapel Hill, NC, and †Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA – Peyronie’s disease (PD) is often physically and psychologically...
Learn more about Minimally invasive treatment of Peyronie’s disease: evidence-based progress
Limited shock wave therapy vs sham treatment in men with Peyronie’s disease: results of a prospective randomized controlled double-blind trial

Limited shock wave therapy vs sham treatment in men with Peyronie’s disease: results of a prospective randomized controlled double-blind trial

Sudhanshu Chitale, Mohammed Morsey, Louise Swift* and Krishna Sethia Department of Urology, Norfolk & Norwich University Hospitals NHS Foundation Trust, and *Department of Medical Statistics, School of Medicine Health Policy and Practice, University of East Anglia, Norwich, UK – To assess...
Learn more about Limited shock wave therapy vs sham treatment in men with Peyronie’s disease: results of a prospective randomized controlled double-blind trial
Shockwave Therapy Improves Erectile Function and Quality of Life in Patients with Peyronie’s Disease

Shockwave Therapy Improves Erectile Function and Quality of Life in Patients with Peyronie’s Disease

Title of study: A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie’s Disease Authors: Alessandro Palmieri, Ciro Imbimbo, Nicola Longo, Ferdinando Fusco, Paolo Verze, Francesco Mangiapia, Massimiliano Creta *, Vincenzo Mirone...
Learn more about Shockwave Therapy Improves Erectile Function and Quality of Life in Patients with Peyronie’s Disease
​Role of extracorporeal shock wave therapy in management of Peyronie’s disease: A preliminary report

​Role of extracorporeal shock wave therapy in management of Peyronie’s disease: A preliminary report

Rajendra Kashinath Shimpi, Ravi Jineshkumar Jain Department of Urology and Genito-Urinary Surgery, Ruby Hall Clinic, Pune, Maharashtra, India – Peyronie’s Disease (PD) is a disease causing psycho social trauma to the patient. Multiple treatment options are available with variable results. Extra...
Learn more about ​Role of extracorporeal shock wave therapy in management of Peyronie’s disease: A preliminary report
Shockwave Therapy as First-Line Treatment for Peyronie’s Disease: A Prospective Study

Shockwave Therapy as First-Line Treatment for Peyronie’s Disease: A Prospective Study

A. SKOLARIKOS, M.D., ALARGOF, M.D., RIGAS, M.D., DELIVELIOTIS, M.D. and E. KONSTANTINIDIS, M.D – To assess in a prospective study whether shockwave therapy (SWT) is effective as a first-line treatment for Peyronie’s disease. Click here to read more.
Learn more about Shockwave Therapy as First-Line Treatment for Peyronie’s Disease: A Prospective Study
Extracorporeal Shock Wave Therapy in Peyronie’s Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study

Extracorporeal Shock Wave Therapy in Peyronie’s Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study

Urology Section, Department of Surgery, University of Catania, Catania, Department of Urology, University of Florence, Andrology Center, Villa Donatello Hospital, Florence, Department of Urology, University of Naples, Naples, Department of Urology, Molinette Hospital, University of Turin, Turin, Department of Urology, University...
Learn more about Extracorporeal Shock Wave Therapy in Peyronie’s Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study
Peyronie’s disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men

Peyronie’s disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men

Eric Chung, University of Queensland, Department of Urology, Princess Alexandra Hospital, Brisbane, AndroUrology Centre, St Andrew’s War Memorial Hospital, Brisbane, QLD, Australia. Purpose: To evaluate the efficacy, safety and patient satisfaction outcomes following low intensity extracorporeal shock wave therapy (LiESWT)...
Learn more about Peyronie’s disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men
Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie’s Disease

Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie’s Disease

Elliot B. Lander, MD, Mark H. Berman, MD, Jackie R. See, MD – This pilot study was used to evaluate safety and subjective out-comes in a small series of Peyronie’s disease patients using a combination of autologous stromal vascular fraction (SVF)...
Learn more about Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie’s Disease
Shock wave therapy for systemic sclerosis

Shock wave therapy for systemic sclerosis

We studied the effects of ESWT in 8 SSc female patients who received 4 consecutive ESWT sessions (Dermagold– MTS Germany defocused lithotripter device, 10.000 shots/ session applied at the energy level of 0.06 mJ/mmq, frequency of 5 Hz), weekly applied...
Learn more about Shock wave therapy for systemic sclerosis
Shock Wave Therapy Improves Erectile Dysfunction in Patients

Shock Wave Therapy Improves Erectile Dysfunction in Patients

Title of study: Effectiveness of Shock Wave Therapy: Implementation of a Soft Wide Focus Applicator in Patients with Erectile Dysfunction Authors: José Pablo Saffon, Juan Manuel Martínez, Carolina Sandoval, Héctor A. Corredor A new study published in the journal Actas...
Learn more about Shock Wave Therapy Improves Erectile Dysfunction in Patients